183 related articles for article (PubMed ID: 36225625)
41. Germline and somatic mutations of the
Kumamoto K; Ishida H; Ohsawa T; Ishibashi K; Ushiama M; Yoshida T; Iwama T
Oncol Lett; 2015 Oct; 10(4):2239-2243. PubMed ID: 26622826
[TBL] [Abstract][Full Text] [Related]
42. Novel and reported APC germline mutations in Chinese patients with familial adenomatous polyposis.
Zhang S; Qin H; Lv W; Luo S; Wang J; Fu C; Ma R; Shen Y; Chen S; Wu L
Gene; 2016 Feb; 577(2):187-92. PubMed ID: 26625971
[TBL] [Abstract][Full Text] [Related]
43. Identification a nonsense mutation of
Li H; Zhang L; Jiang Q; Shi Z; Tong H
Exp Ther Med; 2017 Apr; 13(4):1495-1499. PubMed ID: 28413499
[TBL] [Abstract][Full Text] [Related]
44. Mutation analysis of the APC gene in unrelated Korean patients with FAP: four novel mutations with unusual phenotype.
Han SH; Ryu JS; Kim YJ; Cho HI; Yang YH; Lee KR
Fam Cancer; 2011 Mar; 10(1):21-6. PubMed ID: 21110124
[TBL] [Abstract][Full Text] [Related]
45. A novel pathogenic large germline deletion in adenomatous polyposis coli gene in a Chinese family with familial adenomatous polyposis.
Zhang Z; Liang S; Huang H; Wang D; Zhang X; Wu J; Chen H; Wang Y; Rong T; Zhou Y; Banerjee S
Oncotarget; 2016 Aug; 7(31):50392-50400. PubMed ID: 27391059
[TBL] [Abstract][Full Text] [Related]
46. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP
Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219
[TBL] [Abstract][Full Text] [Related]
47. Desmoids and genotype in familial adenomatous polyposis.
Church J; Xhaja X; LaGuardia L; O'Malley M; Burke C; Kalady M
Dis Colon Rectum; 2015 Apr; 58(4):444-8. PubMed ID: 25751801
[TBL] [Abstract][Full Text] [Related]
48. Mutation Analysis of the APC Gene in a Chinese FAP Pedigree with Unusual Phenotype.
Chen S; Zhou J; Zhang X; Zhou X; Zhu M; Zhang Y; Ma G; Li J
ISRN Gastroenterol; 2011; 2011():909121. PubMed ID: 22164339
[TBL] [Abstract][Full Text] [Related]
49. Mutational screening through comprehensive bioinformatics analysis to detect novel germline mutations in the APC gene in patients with familial adenomatous polyposis (FAP).
Ghadamyari F; Heidari MM; Zeinali S; Khatami M; Merat S; Bagherian H; Rejali L; Ghasemi F
J Clin Lab Anal; 2021 May; 35(5):e23768. PubMed ID: 33769591
[TBL] [Abstract][Full Text] [Related]
50. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.
Miyaki M; Konishi M; Kikuchi-Yanoshita R; Enomoto M; Igari T; Tanaka K; Muraoka M; Takahashi H; Amada Y; Fukayama M
Cancer Res; 1994 Jun; 54(11):3011-20. PubMed ID: 8187091
[TBL] [Abstract][Full Text] [Related]
51. Somatic APC mosaicism: a frequent cause of familial adenomatous polyposis (FAP).
Aretz S; Stienen D; Friedrichs N; Stemmler S; Uhlhaas S; Rahner N; Propping P; Friedl W
Hum Mutat; 2007 Oct; 28(10):985-92. PubMed ID: 17486639
[TBL] [Abstract][Full Text] [Related]
52. Mutational spectrum of APC and genotype-phenotype correlations in Greek FAP patients.
Fostira F; Thodi G; Sandaltzopoulos R; Fountzilas G; Yannoukakos D
BMC Cancer; 2010 Jul; 10():389. PubMed ID: 20649969
[TBL] [Abstract][Full Text] [Related]
53. Brain tumors in individuals with familial adenomatous polyposis: a cancer registry experience and pooled case report analysis.
Attard TM; Giglio P; Koppula S; Snyder C; Lynch HT
Cancer; 2007 Feb; 109(4):761-6. PubMed ID: 17238184
[TBL] [Abstract][Full Text] [Related]
54. Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis.
Su LK; Barnes CJ; Yao W; Qi Y; Lynch PM; Steinbach G
Am J Hum Genet; 2000 Sep; 67(3):582-90. PubMed ID: 10924409
[TBL] [Abstract][Full Text] [Related]
55. Risk factors for development of desmoid tumours in familial adenomatous polyposis.
Lefevre JH; Parc Y; Kernéis S; Goasguen N; Benis M; Parc R; Tiret E
Br J Surg; 2008 Sep; 95(9):1136-9. PubMed ID: 18581438
[TBL] [Abstract][Full Text] [Related]
56. Clinical characterization and mutation spectrum in Hispanic families with adenomatous polyposis syndromes.
Cruz-Correa M; Diaz-Algorri Y; Mendez V; Vazquez PJ; Lozada ME; Freyre K; Lathroum L; Gonzalez-Pons M; Hernandez-Marrero J; Giardiello F; Rodriguez-Quilichini S
Fam Cancer; 2013 Sep; 12(3):555-62. PubMed ID: 23460355
[TBL] [Abstract][Full Text] [Related]
57. Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals.
Septer S; Slowik V; Morgan R; Dai H; Attard T
Hered Cancer Clin Pract; 2013 Oct; 11(1):13. PubMed ID: 24093640
[TBL] [Abstract][Full Text] [Related]
58. Molecular and clinical study of familial adenomatous polyposis for genetic testing and management.
Li G; Tamura K; Yamamoto Y; Sashio H; Utsunomiya J; Yamamura T; Shimoyama T; Furuyama J
J Exp Clin Cancer Res; 1999 Dec; 18(4):519-29. PubMed ID: 10746979
[TBL] [Abstract][Full Text] [Related]
59. Should children at risk for familial adenomatous polyposis be screened for hepatoblastoma and children with apparently sporadic hepatoblastoma be screened for APC germline mutations?
Aretz S; Koch A; Uhlhaas S; Friedl W; Propping P; von Schweinitz D; Pietsch T
Pediatr Blood Cancer; 2006 Nov; 47(6):811-8. PubMed ID: 16317745
[TBL] [Abstract][Full Text] [Related]
60. High cumulative risk of colorectal cancers and desmoid tumours and fibromatosis in South Asian APC mutation carriers.
Ashar S; Lipsa A; Khan N; Sarin R
J Med Genet; 2022 May; 59(5):492-495. PubMed ID: 33766935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
